halation causes airway inflammation in the early phase, Bronchopulmonary injury secondary to smoke inha-with subsequent pulmonary edema and infection [2] . lation is a significant comorbid factor following major Medical interventions that decrease airway inflammathermal trauma. The present study evaluates the ef-tion may attenuate the later deleterious consequences of fects of pentoxifylline (PTX) on pulmonary function in inhalation injury. an ovine model of inhalation injury. Following smoke Pentoxifylline [3,xanthine, exposure to produce a moderate inhalation injury, 16 PTX] has been advocated for use in patients with animals were divided into two groups. Group 1 animals chronic peripheral vascular insufficiency [3] . PTX ap-(n = 8) were untreated; Group 2 animals (n = 8) were pears to increase the deformability of erythrocytes and treated continuously with pentoxifylline following leukocytes, to decrease plasma fibrinogen levels, to insmoke exposure. The animals were observed in the uncrease the secretion of tissue plasminogen activator, to intubated, awake state for 48 hr. Cardiopulmonary inhibit platelet aggregation, and to increase prostacyclin variables and blood gases were measured serially. Ven-production from endothelal cells [4] [5] [6] . These effects tilation perfusion distribution (VA/Q), analyzed using result in the hemorheologic and antithrombotic properthe multiple inert gas elimination technique, and bronres of the poteologdcran g boticoproperchoaveoar avae (AL)wereperormd a 48hr.ties of PTX, potentially decreasing blood viscosity and choalveolar lavage (BAL) were performed at 48 hr..
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The wet to dry lung weight ratio was measured followimproving microcirculatory blood flow. Recently, the efing necropsy. In Group 2, the progressive hypoxemia fects of PTX on cytokine production and leukocyte actiobserved following smoke inhalation was attenuated vation have been investigated [7] . In in vitro studies, with less VA/Q mismatching than in Group 1 (P < 0.05).
PTX has been reported to block TNF mRNA expression Pulmonary hypertension secondary to increased vascuin macrophages and to inhibit TNF, IL-1, and PAF activlar resistance was also attenuated in Group 2 (P < ity on neutrophils, leading to decreased leukocyte adhe-0.05). In BAL fluid, polymorphonuclear leukocytes, to-sion to endothelium, superoxide production, degranulatal protein content, and conjugated dienes were less in tion, and phagocytosis, as well as increased leukocyte Group 2 than in Group 1 (P < 0.05). Plasma-conjugated migration and chemotaxis [8] [9] [10] [11] [12] . In animal models, diene levels were also lower in Group 2 at 48 hr. Extra-beneficial effects of PTX have been reported following vascular lung water and decrease in lung compliance peritonitis, septicemia, ischemia-reperfusion, and hemwere greater in Group 1. There was less morphologic orrhagic shock [13] [14] [15] [16] [17] [18] . Also, acute lung injury induced evidence of airway injury in Group 2 compared to by TNF, chymotrypsin, and Escherichia coli have been Group 1. The improvement of pulmonary function fol-significantly attenuated with PTX therapy [19] [20] [21] . lowing treatment with PTX suggests that this agent Polymorphonuclear leukocytes (PMNs) have been may be useful in the management of smoke inhalation implicated as a source of oxygen radicals and proteases injury.
which participate in the cascade of events leading to pulmonary damage following smoke exposure. In the present study we evaluated the pulmonary effects of PTX following smoke inhalation injury in an ovine model. Smoke inhalation injury is a significant comorbid factor in patients with major thermal injury [1] . Smoke in-METHODS AND MATERIALS cial chow and water ad libitum. The animals were di-kg, iv; Organon Pharmaceuticals), and mechanically vided into three groups. Group 1 (n = 8) animals re-ventilated. During mechanical ventilation, tidal volume ceived only saline after smoke exposure. Group 2 (n = 8) was set at 15 ml/kg, respiratory rate at 10/min, and posianimals received a continuous intravenous infusion of tive end-expiratory pressure (PEEP) at 5 cm H 2 0. After pentoxifylline (Hoechst-Roussel Pharmaceuticals, Inc., 30 min, ventilation perfusion distribution (VA/Q) using Somerville, NJ) after smoke exposure. Normal control the multiple inert gas elimination technique (MIGET) animals (n = 4) were used for the analyses of normal was measured according to the method developed by ventilation-perfusion distributions in lung, bronchoal-Wagner et al. [22] . Lactated Ringer's solution containveolar lavage fluids, and wet to dry lung weight ratios.
ing six inert gases (sulfur hexafluoride, ethane, cycloThe animals in Groups 1 and 2 were instrumented propane, halothane, diethylether, and acetone) was inwhile under sodium pentobarbital (25 mg/kg, iv; Sigma fused at a rate of 0.1 ml/kg/min. After 30 min, when Chemical Co.) general anesthesia the day prior to smoke equilibrium of gas exchange occurred, samples of arterial exposure. Silastic cannulae were placed in a femoral ar-and mixed venous blood (10 ml each) were drawn anaertery and vein. One radiopaque sheath introducer, obically into preweighed heparinized syringes. Mixed through which a Swan Ganz catheter was placed, was expired gas was collected through a temperature-coninserted into an external jugular vein.
trolled copper coil (o.d. = 3.5 cm, L = 550 cm) 1 min after The following day, the animals were anesthetized with blood sampling. Duplicate blood and expired gas samsodium pentobarbital and intubated with a 7.5-mm oro-ples were immediately analyzed on a Hewlett-Packard tracheal tube. Before smoke exposure, the animals were 5890 Series 2 gas chromatograph (Hewlett-Packard paralyzed with succinylcholine chloride (0.5 mg/kg, iv; Company). VýA/Q distribution was analyzed utilizing a Abbott Laboratories). Smoke was generated by thermo-computer program designed specifically for the analysis lysis of pine woodchips (50 g) in a crucible furnace (Fur-of VA/Q using MIGET. nace Model 56622 and Control Console Model 58114;
After the MIGET study, bronchoalveolar lavage Lindberg, Watertown, WI) at a constant temperature of (BAL) was performed. Twenty milliliters of 0.9% sterile 400'C and a constant airflow of 3 liters/min. Smoke ex-saline was injected into the left lower lobe and the fluid posure was accomplished using a circuit equipped with a was immediately aspirated. This process was repeated volume-controlled pump and a breathhold valve. Moder-three times. The collected fluid was centrifuged and aliate smoke inhalation injury was produced by alternating quots of the supernatent were stored at -70°C until mea-7 units of smoke with 7 units of air; 1 unit consisting of surement of total protein content and conjugated dienes. five breaths at a constant tidal volume of 30 ml/kg with a The cell pellet was resuspended with the same amount of constant breathhold of 4 sec. saline as the supernatant and the total white blood cell After smoke exposure, the animals were housed in in-count was determined using a hemocytometer. Differendividual cages in climate controlled facilities and ob-tial cell counts were performed on Wright-Giemsaserved for 48 hr while breathing spontaneously, in the stained cytocentrifuge preparations. Total protein in the awake state. Group 1 animals received a maintenance BAL fluid supernatant was measured using a spectroinfusion of lactated Ringer's solution (1.5 ml/kg/hr, iv). photometric dye-binding protein assay (Bio-Rad) [23] . Group 2 animals received a bolus injection of pentoxifylConjugated diene levels in the plasma and BAL fluid line (20 mg/kg, iv) immediately following smoke expo-supernatant were measured by the method reported presure, followed by a continuous infusion of pentoxifylline viously [24] . One-half milliliter of plasma or BAL fluid (2 mg/kg/hr, iv) mixed in lactated Ringer's solution (1.5 was mixed with 7.0 ml of a chloroform/methanol (2:1) ml/kg/hr).
solution which was preheated to 45°C. The mixture was Cardiopulmonary variables and blood gases were vortexed vigorously for 2 min and then centrifuged for 5 measured before smoke exposure and at 1, 3, 6, 12, 24, 36, min at 1500g. The lower chloroform layer was carefully and 48 hr following exposure. Pulmonary artery pres-removed and mixed with 2 ml of acidified water (pH 2.5). sure, pulmonary capillary wedge pressure (PCWP), and After the same agitation and centrifugation procedure systemic artery pressure were measured using a pressure was repeated, the lower level was aspirated and dried monitor (Model 78354A; Hewlett-Packard Company). under nitrogen gas. The residue was reconstituted with 2 Cardiac output was measured by thermodilution tech-ml of heptane and the absorbance was measured spectronique (Cardiac Output Computer Model 9520A; Ameri-photometrically at 233 nm. Results are expressed as abcan Edwards Laboratory). Blood gas analyses were per-sorbance at 233 nm against a blank consisting of hepformed using an IL 1303 pH/blood gas analyzer and an tane alone. IL 282 CO-oximeter (Instrumentation Laboratories,
The wet to dry lung weight ratio (W/D) was deterInc.). Plasma samples for the measurement of conju-mined by a modification of the gravimetric method of gated dienes were'stored at -70'C until measurement.
Drake et al. [25] . The right lung was removed after the Forty-eight hours following smoke exposure the ani-bronchi and vessels were ligated. The entire right lung mals were anesthetized with sodium pentobarbital, intu-was homogenized with an identical weight of distilled bated, paralyzed with pancuronium bromide (0.03 mg/ water. Duplicate samples of the homogenate and blood smoke exposure were 71.8 ± 2.2% in Group 1 and 65.1 ± 4.0% in Group 2. This difference was not statistically were weighed and dried at a constant temperature of significant. All animals survived the 48-hr observation 80'C. Dry weights were measured and the wet to dry period. ratios of the homogenate and blood were calculated. A Figure 1 depicts the serial PaO2 following smoke exposample of the homogenate was centrifuged at 14,500 rpm sure. The progressive hypoxemia measured in Group 1 for 1 hr, and a blood sample was diluted with the same was significantly attenuated in Group 2 during the secvolume of distilled water. To determine the hemoglobin ond 24 hr (P < 0.05). levels in the homogenate and blood, 20 /l of the homoge- Figure 2 depicts the serial mean pulmonary artery nate supernatant or the diluted blood was added to 2.5 pressure for the two groups. The elevation of mean pulml of Drabkin's solution. The absorbance of both solu-monary artery pressure in Group 1 was attenuated in tions was measured spectrophotometrically at 540 nm. Group 2. The difference between groups was significant Then, the blood weight in the wet lung was calculated. during the entire second 24 hr. From these data, blood-free wet and dry weights of the Other physiologic parameters are shown in Table 1 . right lung were calculated, and the W/D ratio was deter-The respiratory index in Group 2 was significantly lower mined.
48 hr following smoke exposure compared to that in Static lung compliance was measured before smoke Group 1. The PCWP was significantly lower in Group 2 exposure and 48 hr after smoke exposure, while the during the second 24 hr. The elevation of pulmonary animals were mechanically ventilated. Using an esopha-vascular resistance observed in Group 1 was not present geal balloon, transpulmonary pressure was measured in Group 2 at 48 hr. sure, total peripheral resistance, and cardiac index did fluid in this study was approximately 60%. Total WBC not differ significantly between the two groups through-and PMN counts were significantly greater in Group 1 out the entire study. than in controls or Group 2. Table 2 shows the results of the MIGET analysis. The Figure 4 displays the conjugated diene levels in the mean VA/Q of blood flow distribution, one index of VA/Q BAL fluid from Groups 1 and 2 and normal controls. mismatching, was significantly decreased in Group 1 The level in Group I was significantly greater than that compared to normal. In Group 2, the decrease in mean in normal controls or Group 2. VA/Q was less than that in Group 1, but the difference Figure 5 shows the serial conjugated diene levels in was not statistically significant. The logarithmic stan-plasma for both experimental groups. At 48 hr the difdard deviation of blood flow distribution, another index ference between Group 1 and Group 2 was statistically of VA/Q mismatching, was significantly increased in significant. Group 1 compared to normal. In Group 2, the increase in Figure 6 depicts the total protein content in BAL fluid the log SD Q was significantly less than that in Group 1.
In addition, the percentage of blood flow to the shunt and very low VA/Q area (V7A/Q < 0.1) was greater in 1600 Group 1 than in Group 2 or normal animals. Group 2 (PTX), and normal controls (CONTROL, n = 4). The proThe levels are expressed as absorbance at 233 nm. The conjugated tein content in Group 1 was significantly greater compared to Group 2 diene levels in Group 1 were significantly greater compared to Group 2 or normal controls (*P < 0.05, ANOVA Tukey). or normal controls (*P < 0.05, ANOVA Tukey).
from Groups 1 and 2 and normal controls. BAL protein DISCUSSION content was significantly greater in Group 1 compared Smoke inhalation injury is initiated by noxious chemito Group 2 or normal controls.
cals generated from incomplete combustion of various Figure 7 portrays the wet to dry lung weight ratios at kinds of materials [26] . These stimulants not only di-48 hr following smoke exposure. W/D in Group 1 was rectly injure the exposed airways, but appear to activate significantly greater than that in normal or Group 2.
chemotactic factors which may result in macrophage acThe decrease in static lung compliance at 48 hr, com-tivation [27] . Although the precise mechanism has not pared to the preinjury value, was significantly lower in been clarified, PMNs appear to be modulated by signals Group 2 than in Group 1 (-9.5 ± 3.4% vs -32.3 ± 6.3%, from activated macrophages [28] . In a granulocyte-de-P < 0.05).
pleted sheep model, smoke inhalation injury was signifiThe epithelial damage score at the bronchus level was cantly attenuated compared to controls, supporting the significantly higher in Group 1 than in Group 2 (2.0 ± role of granulocytes in such injury [29] . Activated poly-0.2 vs 1.4 ± 0.1, P < 0.05). Figure 8 shows the morphomorphonuclear cells, which demonstrate enhanced adhelogic changes in the two groups at the level of left seg-siveness to endothelium, superoxide production, and demental bronchus by light and electron microscopy. granulation may cause the progressive airway inflamma- Wet to dry lung weight ratios in Group 1 (SALINE), Group 1 were attenuated in Group 2, and the difference between the Group 2 (PTX), and normal controls (CONTROL, n = 4). W/D in two groups was significant at 48 hr (*P < 0.05, Student's t test at Group 1 was significantly greater compared to Group 2 or normal equivalent time).
controls (*P < 0.05, ANOVA Tukey). tion which follows smoke exposure. During this inflam-line is reported to decrease the F-actin content of PMNs matory process, thromboxane production is increased, and lymphocytes, leading to an increased membrane leading to platelet aggregation in the lung [30] , antipro-skeleton flexibility [43] . tease activity is inhibited [31] , surface tension in the Pentoxifylline has also been reported to inhibit macroalveoli is reduced [32] , and both pulmonary capillaryper-phage TNF production and to inhibit the activity of meability and hydrostatic pressure are increased [33] . In TNF, IL-1, PAF, and GM-CSF on PMNs [8-10, 44]. In addition, the denuded cilia and epithelial cells of the in-addition, pentoxifylline inhibits the function of preactijured airway form pseudomembranes consisting of cellu-vated PMNs, which themselves synthesize and secrete lar debris, mucus, and leukocytes, which may cause oc-cytokines [45] . These in vitro inhibitory effects of penclusion of small airways [2] . This mechanical obstruc-toxifylline on cytokine production and activity might attion, together with deficient alveolar surface tension and tenuate the inflammatory reaction induced by smoke pulmonary edema secondary to increased capillary per-exposure. meability, can significantly increase shunt and low VA/Q In the present study, a continuous infusion of pentoxarea in the lung [34] . Increased VA/Q mismatching re-ifylline following smoke exposure exerted significant sults in hypoxemia following smoke inhalation. Damage anti-inflammatory effects. Progressive postexposure and occlusion of small airways increase the susceptibil-hypoxemia was significantly decreased with treatment, ity to pulmonary infection, enhancing morbidity, and a finding consistent with the observed smaller increase mortality in the later phase of injury [1] . Medical interin ngAconmistcng the smaller inshnand ventions which might attenuate the acute airway inflam-low VA/Q area in the treated animals indicates that matory response have the potential to diminish these treate preserve arway andmalveolar caten the deleterious pulmonary changes. treatment preserved airway and alveolar patency. The Several studies have been published concerning the significant attenuation of airway epithelial damage and interstitial edema with PTX might account for this beneffects of anti-inflammatory drugs following smoke ex-eficial effect. The smaller rise in PMN counts and conposure in ovine models. Treatment with a platelet activating factor antagonist has been reported to attenuate jugated dienes in the BAL fluid from treated animals smoke inhalation injury through modulation of lipid compared to the nontreated group suggest a decrease in peroxidation [35] . The administration of ibuprofen and PMN adhesion and oxidant production in the lung. the nebulization of DMSO with heparin have been reThe smaller increase in extravascular lung water in ported to decrease lung lymph flow and antiprotease ac-pentoxifylline-treated animals may be explained by two tivity following smoke exposure [36, 37] . Furthermore, mechanisms. The first is a smaller increase in pulmothe administration of a synthetic antiprotease (gabex-nary microvascular permeability following smoke expoane mesilate) has been reported to decrease lung lymph sure. In the present study, the decreased total protein in flow and preserve pulmonary function [38] .
the BAL fluid in treated animals supports this mechaPentoxifylline appears to have two major pharmaco-nism. Pentoxifylline may inhibit intercellular gap forlogic effects. One involves its hemorheologic and anti-mation in capillary endothelial and pulmonary epithethrombotic effects, which may improve microcirculatory lial cells by increasing cyclic AMP levels. In addition, blood flow and tissue oxygenation [17, 18] . The other is PTX may decrease the cell membrane damage produced its potential inhibitory effect on cytokine release and by activated PMNs. Another mechanism that may have leukocyte activation, which may attenuate the inflam-contributed to the smaller increase in extravascular lung matory process induced by activated leukocyte/endothe-water is attenuation of pulmonary capillary hypertenlial complex [15] [16] [17] [18] [19] [20] [21] . The mechanisms by which pentox-sion following smoke exposure. In this study, both mean ifylline exerts these effects has not been thoroughly de-pulmonary artery pressure and pulmonary capillary lineated. Pentoxifylline, a methylxanthine, inhibits wedge pressure were significantly lower in the treated cyclic AMP phosphodiesterase and delays the inactiva-animals, compared to the nontreated animals; a resultion of cyclic AMP in cells. Increased intracellular cyclic tant decrease in pulmonary capillary pressure could re-AMP appears to decrease monokine expression, inhibit sult in decreased lung water accumulation. Although the PMN adhesion, and depress superoxide production and treatment with PTX blunted the increase in pulmonary degranulation of activated PMNs [39] . Increased cyclic vascular resistance following smoke inhalation, sys-AMP has also been reported to decrease vascular perme-temic vascular resistance was not influenced by PTX ability and vascular smooth muscle vasoconstriction administration. This is consistent with a previous report [40, 41] . Pentoxifylline has also been reported to regu-in which the vasodilatory effects of pentoxifylline were late signal transduction through modulation of cell sur-observed only in vessels which were previously vasoconface receptors. In in vitro studies, pentoxifylline down-stricted [46] . The attenuation of the pulmonary vascular regulated CD11b/CD18 expression on leukocytes [42] . response could also be secondary to a decrease in hypPentoxifylline also blunted the increase in intracellular oxic pulmonary vasoconstriction; in addition, the hecalcium in PMNs stimulated by FMLP, which served to morheologic effect of PTX might result in a reduction of decrease superoxide production [9] . Further, pentoxifyl-pulmonary capillary vascular resistance. reported to be well tolerated [3] . In one study, a continu-8. Doherty, G. M., Jensen, J. C., Alexander, R., Buresh, C. M., and ous infusion (1.5 mg/kg/hr) for 6 days resulted in no Norton, J. A. The beneficial effects of pentoxifylline therapy follow-11. Williams, J. H., Jr., Heshmati, S., Tamadon, S., and Guerra, J.
ing smoke exposure in this study are probably a result of treatment may be feasible in thermally injured patients.
